Ngā hua rapu - Keith A. Rodvold

Whakamahine hua
  1. 1
    Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline

    Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline mā Keith A. Rodvold, Manjunath P. Pai

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update

    Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update mā Emily N. Drwiega, Keith A. Rodvold

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid

    Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid mā Keith A. Rodvold, Jomy George, Liz Yoo

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Vancomycin for Surgical Prophylaxis?

    Vancomycin for Surgical Prophylaxis? mā Tonya Crawford, Keith A. Rodvold, Joseph S. Solomkin

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Antimicrobial Dosing in Obese Patients

    Antimicrobial Dosing in Obese Patients mā Rebecca Wurtz, Gail S. Itokazu, Keith A. Rodvold

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung

    Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung mā Keith A. Rodvold, William Hope, Sara E. Boyd

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Steady-State Plasma and Bronchopulmonary Concentrations of Intravenous Levofloxacin and Azithromycin in Healthy Adults

    Steady-State Plasma and Bronchopulmonary Concentrations of Intravenous Levofloxacin and Azithromycin in Healthy Adults mā Keith A. Rodvold, Larry H. Danziger, Mark H. Gotfried

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers

    Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers mā Eric Wenzler, Evelyn J. Ellis‐Grosse, Keith A. Rodvold

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Daptomycin: A novel cyclic lipopeptide antimicrobial

    Daptomycin: A novel cyclic lipopeptide antimicrobial mā Christopher Schriever, Cristina Fernández, Keith A. Rodvold, Larry H. Danziger

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    National Survey of Extended-Interval Aminoglycoside Dosing

    National Survey of Extended-Interval Aminoglycoside Dosing mā Susan K. Chuck, Susan Raber, Keith A. Rodvold, D. Areff

    I whakaputaina 2000
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia

    The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia mā Kevin W. McConeghy, Susan C Bleasdale, Keith A. Rodvold

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Innovative approaches to optimizing the delivery of vancomycin in individual patients

    Innovative approaches to optimizing the delivery of vancomycin in individual patients mā Manjunath P. Pai, Michael Neely, Keith A. Rodvold, Thomas P. Lodise

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Comparison of Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Solithromycin (CEM-101) in Healthy Adult Subjects

    Comparison of Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Solithromycin (CEM-101) in Healthy Adult Subjects mā Keith A. Rodvold, Mark H. Gotfried, James Still, Kay Clark, Prabhavathi Fernandes

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Pharmacokinetics and Administration Regimens of Vancomycin in Neonates, Infants and Children

    Pharmacokinetics and Administration Regimens of Vancomycin in Neonates, Infants and Children mā Keith A. Rodvold, Julie A. Everett, Randy D. Pryka, Donna M. Kraus

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers

    Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers mā Keith A. Rodvold, Mark H. Gotfried, Larry H. Danziger, Ronald J. Servi

    I whakaputaina 1997
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects

    Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects mā Gurudatt Chandorkar, Jennifer A. Huntington, Mark H. Gotfried, Keith A. Rodvold, Obiamiwe Umeh

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects

    Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects mā Keith A. Rodvold, Mark H. Gotfried, Robin Isaacs, John P. O’Donnell, Emily Stone

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique

    Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique mā Kyle Vance‐Bryan, David R.P. Guay, Susan S. Gilliland, Keith A. Rodvold, John C. Rotschafer

    I whakaputaina 1993
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Pharmacodynamic Profiling of Piperacillin in the Presence of Tazobactam in Patients through the Use of Population Pharmacokinetic Models and Monte Carlo Simulation

    Pharmacodynamic Profiling of Piperacillin in the Presence of Tazobactam in Patients through the Use of Population Pharmacokinetic Models and Monte Carlo Simulation mā Thomas P. Lodise, Ben M. Lomaestro, Keith A. Rodvold, Larry H. Danziger, George L. Drusano

    I whakaputaina 2004
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous Hemofiltration

    Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous Hemofiltration mā Eric Wenzler, Kristen Bunnell, Susan C Bleasdale, Scott Benken, Larry H. Danziger, Keith A. Rodvold

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: